Your browser doesn't support javascript.
loading
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
Dubberke, Erik R; Lee, Christine H; Orenstein, Robert; Khanna, Sahil; Hecht, Gail; Gerding, Dale N.
Afiliación
  • Dubberke ER; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Lee CH; Hamilton Regional Laboratory Medicine Program, Department of Pathology and Molecular Medicine, McMaster University, Ontario.
  • Orenstein R; Vancouver Island Health Authority, Victoria, British Columbia.
  • Khanna S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Hecht G; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix.
  • Gerding DN; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Clin Infect Dis ; 67(8): 1198-1204, 2018 09 28.
Article en En | MEDLINE | ID: mdl-29617739

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Biológica / Enterocolitis Seudomembranosa / Clostridioides difficile / Infecciones por Clostridium / Microbiota / Antibacterianos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia Biológica / Enterocolitis Seudomembranosa / Clostridioides difficile / Infecciones por Clostridium / Microbiota / Antibacterianos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article